Xanomeline tartrate is a muscarinic acetylcholine receptor agonist with functional selectivity mainly for the M1 and M4 muscarinic receptors. It acts by stimulating these receptors in the central nervous system, leading to cognitive enhancement and antipsychotic-like effects. Because of its M1 receptor agonism, it has been investigated for treating cognitive decline in Alzheimer’s disease and schizophrenia. Xanomeline exhibits strong and persistent binding to muscarinic receptors, which prolongs its effects even after the drug is removed. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Xanomeline L-tartrate and Xanomeline hydrogen tartrate. Its PubChem CID is 71456.
Xanomeline tartrate
| CAS No | 152854-19-8 |
|---|---|
| Molecular Formula | C18H29N3O7S |
| Molecular Weight | 431.50 g/mol |
| Synonyms | (2R,3R)-2,3-dihydroxybutanedioic acid;3-hexoxy-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Xanomeline tartrate is a muscarinic acetylcholine receptor agonist with functional selectivity mainly for the M1 and M4 muscarinic receptors. It acts by stimulating these receptors in the central nervous system, leading to cognitive enhancement and antipsychotic-like effects.
The listed CAS number is 152854-19-8.
The listed molecular formula is C18H29N3O7S.
The listed molecular weight is 431.50 g/mol.
(2R,3R)-2,3-dihydroxybutanedioic acid;3-hexoxy-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole.
The source lists Xanomeline L-tartrate and Xanomeline hydrogen tartrate.